- 201. macrolide antibiotic
- [group of macrocyclic compounds with antibiotic action, formed by chain extension of multiple proprionates and cyclized into a large lactone; often glycosylated. ( CSP )] (UMLS (CSP) C0003240) =Organic Chemical; Antibiotic
| - 251. MAGE-10.A2/Melan-A/NY-ESO-1 peptide vaccine/Sargramostim/tyrosinase peptide
- (UMLS (NCI) C1134658) =Therapeutic or Preventive Procedure
|
- 202. Macromolecular Structure
- [Any very large complex molecule including, proteins, nucleic acids and carbohydrates. ( NCI )] (UMLS (NCI) C0026383) =Molecular Sequence ;
| - 252. MAGE-10.A2/Melan-A/NY-ESO-1 peptide vaccine/Tyrosinase peptide
- (UMLS (NCI) C1134657) =Therapeutic or Preventive Procedure
|
- 203. macromolecule
- [very large molecule having a polymeric chain structure as in proteins, polysaccharides, DNA, and other natural and synthetic polymers. ( CSP )] (UMLS (CSP) C0178735) =Chemical Viewed Structurally ;
=molecular size;
| - 253. MAGE-12 Peptide Vaccine
- [A synthetic vaccine comprised of a peptide consisting of peptide fragments of melanoma-associated antigen 12 (MAGE-12). MAGE-12 has been identified as an epitope recognized by tumor infiltrating lymphocytes (TIL). Vaccination with MAGE-12 peptide stimulates the host immune system to mount a TIL response against tumor cells expressing MAGE-12, potentially resulting in decreased tumor growth. ( NCI )] (UMLS (NCI) C0935670) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor
|
- 204. macrophage activating factor
- [factors secreted by stimulated lymphocytes that prime macrophages to become nonspecifically cytotoxic to tumors and modulate the expression of macrophage cell surface Ia antigens; interferon-gamma is a macrophage activating factor, and other factors antigenically distinct from interferon-gamma have also been identified. ( CSP )] (UMLS (CSP) C0079786) =Organic Chemical; Immunologic Factor ;
=lymphokine;
| - 254. MAGE-12 peptide vaccine/Montanide ISA-51
- (UMLS (NCI) C0935671) =Therapeutic or Preventive Procedure
|
- 205. macrophage activation
- [The process of altering the morphology and functional activity of macrophages so that they become avidly phagocytic. It is initiated by lymphokines, such as the macrophage activation factor (MAF) and the macrophage migration-inhibitory factor (MMIF), immune complexes, C3b, and various peptides, polysaccharides, and immunologic adjuvants. ( MSH )] (UMLS (CSP) C0024426) =Cell Function ;
| - 255. MAGE-3
- [Expressed only in normal testis and placenta by human MAGEA3 Gene, MAGE-3.1 Antigen has an unknown function. (NCI) ( NCI )] (UMLS (NCI) C0962473) MAGE-3 Antigen;
MAGE-3.1 Antigen;
MAGEA3;
=Amino Acid, Peptide, or Protein; Immunologic Factor ;
|
- 206. Macrophage Colony-Stimulating Factor/Monoclonal Antibody R24
- (UMLS (NCI) C0280988) =Therapeutic or Preventive Procedure
| - 256. MAGE-3
- [A recombinant tumor-specific melanoma antigen. Vaccination with recombinant MAGE-3.1 antigen may induce a host immune response against MAGE-expressing cells, resulting in antitumoral T cell-mediated cytotoxicity. MAGE-expressing cells are found in melanoma, non-small-cell lung carcinoma (NSCLC), head and neck squamous cell carcinoma, transitional cell carcinoma of the bladder, and esophageal carcinoma. (NCI04) ( NCI )] (UMLS (NCI) C1510427) MAGE-3.1;
Recombinant MAGE-3.1 Antigen =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor |
- 207. macrophage fusion factor
- [ ] (UMLS (CSP) C0598794) =Amino Acid, Peptide, or Protein; Immunologic Factor
| - 257. MAGE-3.1/PADRE 965.10
- (UMLS (NCI) C0879247) MAGE-3/PADRE 965.10;
=Therapeutic or Preventive Procedure |
- 208. macrophage inflammatory protein
- [heparin-binding proteins which exhibit inflammatory and immunoregulatory activities; they are produced by a variety of cell types including neutrophils, fibroblasts, and epithelial cells; they most likely play a significant role in respiratory tract defenses. ( CSP )] (UMLS (CSP) C0376579) =Amino Acid, Peptide, or Protein; Immunologic Factor ;
=chemoattractant cytokine;
| - 258. MAGE-3/SB AS-2
- (UMLS (NCI) C0879284) =Therapeutic or Preventive Procedure
|
- 209. Macrophage Migration Inhibitory Factor (Glycosylation-Inhibiting Factor) Gene
- [This gene plays a role in cell-mediated immunity and macrophage function. ( NCI )] (UMLS (NCI) C1334507) MIF;
MIF Gene;
=Gene or Genome ;
| - 259. MAGE12
- [This gene may be involved in carcinogenesis. ( NCI )] (UMLS (NCI) C1416973) MAGEA12 Gene;
Melanoma Antigen Family A, 12 Gene =Gene or Genome ◊ [Expressed only in normal testis by human MAGEA12 Gene (MAGE Family), 314-aa 35-kDa MAGE-12 Antigen is a tumor-specific antigen of unknown function recognized by autologous cytolytic T lymphocytes and containing a MAGE domain. (NCI) ( NCI )] (UMLS (NCI) C1449389) MAGE-12 Antigen; MAGEA12; Melanoma Antigen Family A 12; Amino Acid, Peptide, or Protein; Immunologic Factor |
- 210. macrophage product
- [ ] (UMLS (CSP) C0598896) =Immunologic Factor ;
| - 260. MAGEA3
- [This gene may be involved in embryonal development. It may also play a role in carcinogenesis. ( NCI )] (UMLS (NCI) C0677907) =Gene or Genome ;
|
- 211. Macrophage Stimulating 1 Receptor (C-MET-Related Tyrosine Kinase) Gene
- [This gene plays a diverse regulatory role in several processes such as: proliferation, migration, host defense and fertilization. ( NCI )] (UMLS (NCI) C1364082) MST1R;
MST1R Gene =Gene or Genome | - 261. MAGED1
- [Encoded by MAGED1 Gene (MAGE Family), ubiquitous 778-amino acid 86-kD cytoplasmic NRAGE Protein contains a 200-amino acid MAGE homology domain. NRAGE appears to shift from cytoplasm to plasma membrane upon NGF stimulation to interact with p75NTR. NRAGE antagonizes p75NTR association with TRKA, inhibits cell cycle progression, and facilitates p75NTR-mediated apoptosis. NRAGE may regulate the function of DLX family members. (from LocusLink, Swiss-Prot, OMIM, and NCI) ( NCI )] (UMLS (NCI) C0960824) MAGE-D1 Antigen;
Melanoma-Associated Antigen D1;
NRAGE Protein;
PRO2292;
Urotrophin Receptor-Interacting MAGE Homolog Protein =Amino Acid, Peptide, or Protein; Biologically Active Substance |
- 212. Macrophages
- (UMLS (HL7) C1546706) =Intellectual Product =Specimen Source Codes;
| - 262. MAGED1
- [This gene is a member of the melanoma antigen gene family and facilitates cell death. ( NCI )] (UMLS (NCI) C1334472) MAGED1 Gene;
Melanoma Antigen Family D, 1 Gene =Gene or Genome |
- 213. Macrophages
- (UMLS (HL7) C1550652) =Body Substance =SpecimenEntityType;
| - 263. maggot
- [ ] (UMLS (CSP) C0016386) =Invertebrate
|
- 214. Macropodidae
- [A family of herbivorous leaping MAMMALS of Australia, New Guinea, and adjacent islands. Members include kangaroos, wallabies, quokkas, and wallaroos. ( MSH )] (UMLS (CSP) C0324695) =Mammal
| - 264. Magnesium
- [A measurement of the magnesium in a biological specimen. ( NCI )] (UMLS (NCI) C0373675) =Laboratory Procedure
|
- 215. Macroscopic observation
- [Visual, Macroscopic observation ( HL7V3.0 )] (UMLS (HL7) C1551402) =Laboratory Procedure =ObservationMethod;
| - 265. Magnesium Acetate Tetrahydrate
- [The hydrated acetate salt form of magnesium. Magnesium is a divalent cation essential for a number of biochemical processes involved in nerve signaling, bone mineralization and muscle contractions. About 350 enzymes involved in glycolysis and the Krebs cycle, formation of cyclic-AMP and ATP, cellular signal transduction and protein and nucleic acid synthesis are dependent on magnesium. ( NCI )] (UMLS (NCI) C0991847) MAGNESIUM ACETATE TETRAHYDRATE PREPARATION;
=Organic Chemical; Pharmacologic Substance ;
=Unclassified Ingredients;
Inactive Ingredient Preparations =MAGNESIUM ACETATE TETRAHYDRATE 32 MG/100ML;
MAGNESIUM ACETATE TETRAHYDRATE 54 MG |
- 216. MACROSTOMIA
- [Greatly exaggerated width of the mouth, resulting from failure of union of the maxillary and mandibular processes, with extension of the oral orifice toward the ear. The defect may be unilateral or bilateral. (Dorland, 27th ed) ( MSH )] (UMLS (ICD9CM) C0024433) =Congenital Abnormality ;
=Mouth Abnormalities;
| - 266. MAGNESIUM CARBONATE
- (UMLS (NCI) C0065517) =Pharmacologic Substance; Inorganic Chemical ;
=[TN406] MAGNESIUM;
[PH000] PHARMACEUTICAL AIDS / REAGENTS =ASA 500MG/CA CARB/MG CARB/MG OXIDE TAB;
AL OH 150MG/ASA 325MG/MG OH 150MG TAB;
CORN STARCH/METHYLBENZETHONIUM CL 0.055% PWDR,TOP;
MAGNESIUM CARBONATE BLOCKS;
QUINAPRIL 10 MG / QUINAPRIL HYDROCHLORIDE ORAL TABLET, FILM COATED;
quinapril 20 MG Oral Tablet;
quinapril 5 MG Oral Tablet;
QUINAPRIL 40 MG ORAL TABLET;
MAGNESIUM CARBONATE 260 MG;
MAGNESIUM CARBONATE 137.3 MG/5ML;
MAGNESIUM CARBONATE 400 MG;
MAGNESIUM CARBONATE 400 MG/5ML;
MAGNESIUM CARBONATE 97 MG;
MAGNESIUM CARBONATE 105 MG;
MAGNESIUM CARBONATE 232 MG;
MAGNESIUM CARBONATE 350 MG/5ML;
MAGNESIUM CARBONATE 300 MG;
MAGNESIUM CARBONATE 200 MG;
MAGNESIUM CARBONATE 57 MG;
MAGNESIUM CARBONATE 34 MG;
MAGNESIUM CARBONATE 160 MG;
MAGNESIUM CARBONATE 130 MG;
MAGNESIUM CARBONATE 100 MG;
MAGNESIUM CARBONATE 120 MG;
MAGNESIUM CARBONATE 238 MG/5ML;
MAGNESIUM CARBONATE 137.5 MG/5ML;
MAGNESIUM CARBONATE 3.177 GM/100ML;
MAGNESIUM CARBONATE 41.7 MG |
- 217. MACROTIA
- (UMLS (ICD9CM) C0152421) =Congenital Abnormality ;
| - 267. MAGNESIUM CHLORIDE
- [Magnesium Chloride was used as a laxative. An alkaline earth metal, magnesium is important for many biochemical functions and reactions; for bone and muscle function, protein and fatty acid formation, activation of B vitamins, blood clotting, insulin secretion, and ATP formation. More than 300 enzymes require magnesium for catalytic action. The adult daily requirement is about 300 mg/day. Magnesium is found in many green plants, vegetables, and seeds; chlorophyll is a magnesium-centered porphyrin compound. Magnesium salts are used for magnesium deficiency supplementation. (NCI04) ( NCI )] (UMLS (NCI) C0024472) =Pharmacologic More…
|
- 218. Macrotrabecular Hepatoblastoma
- [A pure fetal or fetal and embryonal epithelial hepatoblastoma characterized by the presence of broad trabeculae. ( NCI )] (UMLS (NCI) C1334543) =Neoplastic Process
| - 268. MAGNESIUM CLOFIBRATE
- (UMLS (NCI) C0771940) =Organic Chemical; Pharmacologic Substance ;
|
- 219. Macrotrabecular Pattern
- (UMLS (NCI) C1334544) =Finding
| - 269. magnesium deficiency
- [condition due to decreased dietary intake of magnesium, as in starvation or failure to administer in intravenous solutions, or to gastrointestinal loss; deficiency causes irritability of the nervous system with tetany, vasodilation, convulsions, tremors, depression, and psychotic behavior. ( CSP )] (UMLS (CSP) C0024473) =Disease or Syndrome ;
=Deficiency Diseases;
dietary deficiency;
metal metabolism disorder;
|
- 220. MACS
- [ ] (UMLS (CSP) C0599662) =Laboratory Procedure
| - 270. MAGNESIUM HYDROXIDE
- [A solution of magnesium hydroxide with antacid and laxative properties. Milk of magnesium exerts its antacid activity in low doses such that all hydroxide ions that enter the stomach are used to neutralize stomach acid. This agent exerts its laxative effect in higher doses so that hydroxide ions are able to move from the stomach to the intestines where they attract and retain water, thereby increasing intestinal movement (peristalsis) and inducing the urge to defecate. ( NCI )] (UMLS (NCI) C0024476) =Pharmacologic Substance; Inorganic Chemical =Hydroxides;
[TN406] MAGNESIUM;
Magnesium Compounds;
[GA202] HYPEROSMOTIC LAXATIVES;
[GA108] MAGNESIUM CONTAINING ANTACIDS;
=magaldrate;
aluminum magnesium hydroxide;
AL OH 150MG/ASA 325MG/MG OH 150MG TAB;
CASCARA/MAGNESIUM HYDROXIDE CONC SUSP;
NEPRO LIQUID VANILLA;
MAGNESIUM HYDROXIDE 160 MG;
MAGNESIUM HYDROXIDE 200 MG;
MAGNESIUM HYDROXIDE 300 MG;
MAGNESIUM HYDROXIDE 311 MG;
MAGNESIUM HYDROXIDE 200 MG/5ML;
MAGNESIUM HYDROXIDE 400 MG;
MAGNESIUM HYDROXIDE 300 MG/5ML;
MAGNESIUM HYDROXIDE 75 MG;
MAGNESIUM HYDROXIDE 80 MG;
MAGNESIUM HYDROXIDE 400 MG/5ML;
MAGNESIUM HYDROXIDE 103 MG/5ML;
MAGNESIUM HYDROXIDE 325 MG;
MAGNESIUM HYDROXIDE 165 MG;
MAGNESIUM HYDROXIDE 50 MG;
MAGNESIUM HYDROXIDE 450 MG/5ML;
MAGNESIUM HYDROXIDE 225 MG/5ML;
Magnesium Hydroxide 16 MG/ML;
MAGNESIUM HYDROXIDE 130 MG;
MAGNESIUM HYDROXIDE 5 MG;
MAGNESIUM HYDROXIDE 450 MG/ML;
MAGNESIUM HYDROXIDE 128 MG;
MAGNESIUM HYDROXIDE 100 MG;
Magnesium Hydroxide 120 MG/ML;
MAGNESIUM HYDROXIDE 1200 MG/5ML;
MAGNESIUM HYDROXIDE 350-425 MG/5ML;
|
- 221. macula
- [ ] (UMLS (CSP) C0227662) =Body Part, Organ, or Organ Component ◊ [An oval area in the retina, 3 to 5 mm in diameter, usually located temporal to the posterior pole of the eye and slightly below the level of the optic disk. It is characterized by the presence of a yellow pigment diffusely permeating the inner layers, contains the fovea centralis in its center, and provides the best phototropic visual acuity. It is devoid of retinal blood vessels, except in its periphery, and receives nourishment from the choriocapillaris of the choroid. (From Cline et al., Dictionary of Visual Science, 4th ed) ( MSH )] (UMLS (CSP) C0450295) Body Part, Organ, or Organ Component ;
| - 271. magnesium ion
- [divalent cation of magnesium essential in nutrition. ( CSP )] (UMLS (CSP) C0596876) =Biologically Active Substance; Element, Ion, or Isotope =ion;
|
- 222. Macula of Saccule
- (UMLS (NCI) C0229468) =Body Part, Organ, or Organ Component
| - 272. MAGNESIUM TRISILICATE
- (UMLS (NCI) C0065533) =Pharmacologic Substance; Inorganic Chemical ;
=[TN406] MAGNESIUM;
Magnesium Silicates;
[GA108] MAGNESIUM CONTAINING ANTACIDS;
=MAGNESIUM TRISILICATE 20 MG;
magnesium trisilicate 250 MG;
MAGNESIUM TRISILICATE 400 MG/5ML;
MAGNESIUM TRISILICATE 455 MG;
MAGNESIUM TRISILICATE 40 MG;
|
- 223. Macula of Utricle
- (UMLS (NCI) C0229451) =Body Part, Organ, or Organ Component
| - 273. MAGNET REMOV ANT SEG FB
- [ ] (UMLS (ICD9CM) C0197593) =Therapeutic or Preventive Procedure
|
- 224. Macular Corneal Dystrophy
- (UMLS (NCI) C0024439) =Disease or Syndrome ;
| - 274. MAGNET REMOV POST SEG FB
- [ ] (UMLS (ICD9CM) C0197806) =Therapeutic or Preventive Procedure
|
- 225. MACULAR CYST OR HOLE
- [ ] (UMLS (ICD9CM) C1261331) Macular cyst, hole, or pseudohole of retina;
=Acquired Abnormality; Disease or Syndrome | - 275. MAGNET REMOVAL CORNEA FB
- [ ] (UMLS (ICD9CM) C0844519) Magnetic removal of embedded foreign body from cornea =Therapeutic or Preventive Procedure
|
- 226. Macular degeneration
- [deterioration of the macula lutea in the retina; may be inherited, drug induced, or due to aging; leads to a severe loss of central vision while peripheral vision is retained.(CSP)] (UMLS (ICPC) C0024437) (Macular degeneration; ORBAINAREN ENDAKATZEA; Makula-degeneration; Macula degeneratie; MAKULADEGENERAATIO, TARKAN NAON ALUEEN RAPPEUMA; Degenerescence maculaire; Maculadegeneration; (108); macula-degeneracio; Degenerazione della macula; MAKULADEGENERASJON; Degenerescencia macular; Degeneracion macular; DEGENERATION AV MACULA) =Disease or Syndrome ;
=EYE; Degeneration of retina; Diagnosis/Diseases Component; =Cystoid Macular Edema | - 276. MAGNET REMOVE FB LENS
- [ ] (UMLS (ICD9CM) C0197743) =Therapeutic or Preventive Procedure
|
- 227. macular drusen
- [tiny, white hyaline deposits that are lodged between the retina and the retinal pigment epithelium; they are a physical finding in age related macular degeneration. ( CSP )] (UMLS (CSP) C0677628) =Disease or Syndrome =ANDRE NETTHINNESYKDOMMER - h35.0;
| - 277. magnetic
- [processes and behaviors associated with magnetic fields. ( CSP )] (UMLS (CSP) C0563532) =Natural Phenomenon or Process =Physical Phenomenon;
=magnetic field;
biomagnetism;
|
- 228. Macular Hole
- (UMLS (NCI) C0024441) =Acquired Abnormality; Disease or Syndrome
| - 278. magnetic beads
- [ ] (UMLS (CSP) C1328924) =Natural Phenomenon or Process; ;
|
- 229. MACULAR KERATITIS
- [ ] (UMLS (ICD9CM) C0155076) =Disease or Syndrome ;
| - 279. magnetic colloid
- [ ] (UMLS (CSP) C0598192) =Biomedical or Dental Material
|
- 230. MACULAR PUCKERING
- [ ] (UMLS (ICD9CM) C0154853) =Disease or Syndrome
| - 280. magnetic field
- [portion of space near a magnetic body or a current-carrying body in which the magnetic forces due to the body or current can be detected. ( CSP )] (UMLS (CSP) C0563533) =Natural Phenomenon or Process =magnetic;
=TMS |
- 231. MACULAR SCARS NEC
- [ ] (UMLS (ICD9CM) C0154886) =Disease or Syndrome
| - 281. Magnetic flux
- (UMLS (HL7) C1547031) =Quantitative Concept =Kind of quantity;
|
- 232. MAD
- [Expression of the c-myc gene, which produces an oncogenic transcription factor, is tightly regulated in normal cells but is frequently deregulated in human cancers. MAX Interacting Protein 1, encoded by the MXI1 gene, is a transcriptional repressor thought to negatively regulate MYC function, and is therefore a potential tumor suppressor. This protein inhibits the transcriptional activity of MYC by competing for MAX, another basic helix-loop-helix protein that binds to MYC and is required for its function. Defects in this gene are frequently found in patients with prostate tumors. Two transcript variants encoding different isoforms have been identified for the MXI1 gene. (from LocusLink and NCI) ( NCI )] (UMLS (NCI) C0212908) =Amino Acid, Peptide, or Protein; Biologically Active Substance
| - 282. magnetic recording system
- [ ] (UMLS (CSP) C0596877) =Intellectual Product ;
=biomedical automation;
|
- 233. MAD Homolog 3
- [Regulated by TGF-beta receptors, Mothers Against Decapentaplegic Homolog 3 is an effector of the TGF-beta response. MADH3 is associated with and phosphorylated by the ligand-bound receptor complex. MADH3 and MADH4 synergize to induce strong TGF-beta-like responses. SMAD3 and SMAD4 proteins specifically recognize an eight base pair palindromic DNA sequence that confers TGF-beta responsiveness to a minimal promoter. (from OMIM 603109 and NCI) ( NCI )] (UMLS (NCI) C0529119) =Amino Acid, Peptide, or Protein; Biologically Active Substance
| - 283. MAGNETIC RES IMAGE UNSP
- (UMLS (ICD9CM) C0024486) =Diagnostic Procedure ;
|
- 234. mad itch virus
- [ ] (UMLS (CSP) C0599502) =Virus ;
| - 284. Magnetic resonance
- [Computed, Magnetic resonance ( HL7V3.0 )] (UMLS (HL7) C1551403) =Laboratory Procedure =ObservationMethod;
|
- 235. MADD
- [This proto-oncogene is involved in the regulation of apoptosis and propagates cell death via signal transduction. ( NCI )] (UMLS (NCI) C1366909) MADD Gene;
MAP-Kinase Activating Death Domain Gene;
=Gene or Genome ;
| - 285. Magnetic Resonance
- [A physical phenomenon involving the interaction of atomic nuclei placed in an external magnetic field with an applied electromagnetic field oscillating at a particular frequency. Magnetic conditions within the material are measured by monitoring the radiation absorbed and emitted by the atomic nuclei. It is the underlying principle of Magnetic Resonance Imaging (MRI). ( NCI )] (UMLS (NCI) C0028580) =Natural Phenomenon or Process ;
|
- 236. MADELUNG'S DEFORMITY
- (UMLS (ICD9CM) C0152441) =Congenital Abnormality
| - 286. Magnetic resonance angiography
- [Non-invasive method of vascular imaging and determination of internal anatomy without injection of contrast media or radiation exposure. The technique is used especially in CEREBRAL ANGIOGRAPHY as well as for studies of other vascular structures. ( MSH )] (UMLS (HL7) C0243032) =Diagnostic Procedure ;
=Modality;
|
- 237. Madin Darby canine kidney cell
- [cell line derived from the kidney of an apparently normal, adult, female cocker spaniel; used in numerous viral studies; susceptible to vesicular stomatitis, vaccinia, and Coxsackie viruses, and certain reoviruses and adenoviruses. ( CSP )] (UMLS (CSP) C0598829) =Cell ;
=cell line;
| - 287. Magnetic Resonance Imaging
- (UMLS (HL7) C1552358) =Professional or Occupational Group =Radiologic Technologist;
|
- 238. MADM
- [Expressed by human NRBP Gene, ubiquitous 535-aa 60-kDa Nuclear Receptor Binding Protein is a putative adaptor protein containing 2 putative nuclear receptor-binding motifs, a putative binding domain for SH2 domain-containing proteins, a kinase-like domain, a bipartite nuclear localization signal, and 3 PEST sequences. Mouse and rat NRBP homologs exhibit 91% and 89% identity with NRBP. (NCI) ( NCI )] (UMLS (NCI) C1144459) Multiple Domain Putative Nuclear Protein;
Myeloid Leukemia Factor 1 Adaptor Molecule;
NRBP;
Nuclear Receptor Binding Protein;
xMUDPNP;
=Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 288. magnetic resonance imaging
- [non-invasive method of demonstrating internal anatomy based on the principle that atomic nuclei in a strong magnetic field absorb pulses of radiofrequency energy and emit them as radiowaves which can be reconstructed into computerized images; concept includes proton spin tomographic techniques. ( CSP )] (UMLS (NCI) C0024485) =Diagnostic Procedure ;
=imaging/visualization/scanning;
nuclear magnetic resonance spectroscopy =fMRI;
diffusion magnetic resonance imaging;
|
- 239. Madurella
- [A mitosporic fungal genus that causes MADUROMYCOSIS (mycetoma) in humans. Madurella grisea and M. mycetomatis are the etiological agents. ( MSH )] (UMLS (CSP) C0024448) =Fungus ;
| - 289. Magnetic Resonance Imaging (MRI)
- (UMLS (HL7) C1552430) =Intellectual Product ;
=Clinic/Center;
|
- 240. MAE Regimen
- [A regimen consisting of cytarabine (Ara-C), mitoxantrone and etoposide, used as an induction treatment for pediatric acute myeloid leukemia (AML). ( NCI )] (UMLS (NCI) C0765500) Mitoxantrone-AraC-Etoposide Regimen;
Mitoxantrone-Cytarabine-Etoposide Regimen;
MRC AML10 Study-MAE Regimen;
=Therapeutic or Preventive Procedure | - 290. Magnetic Resonance Imaging (MRI)
- (UMLS (HL7) C1555766) =Intellectual Product =Internal Medicine;
|
- 241. MAF
- [This gene plays a role in transcriptional regulation and cellular differentiation. ( NCI )] (UMLS (NCI) C0919481) MAF Family Gene;
MAF Gene;
v-MAF Musculoaponeurotic Fibrosarcoma Oncogene Homolog (Avian) Gene =Gene or Genome ;
◊ [MAF Protein contains a leucine zipper motif similar to that in many bZIP DNA binding proteins, including FOS, JUN, and MYC oncogenes. Members of the MAF family appear to play important roles in the regulation of differentiation. (from OMIM 177075 and NCI) ( NCI )] (UMLS (NCI) C0919482) MAF Family Protein; MAF Protein; MAF Proteins Amino Acid, Peptide, or Protein; Biologically Active Substance | - 291. Magnetic resonance imaging of brain and brain stem
- [ ] (UMLS (ICD9CM) C0412675) =Diagnostic Procedure
|
- 242. MAFENIDE
- [A sulfonamide that inhibits the enzyme carbonic anhydrase and is used as topical anti-infective, especially in burn therapy. ( MSH )] (UMLS (NCI) C0024452) =Organic Chemical; Pharmacologic Substance =sulfonamide;
[OR900] DENTAL AND ORAL AGENTS, TOPICAL OTHER =4-(Aminomethyl)benzenesulfonamide Monoacetate;
MAFENIDE 6 MG;
| - 292. Magnetic resonance imaging of chest and myocardium
- [ ] (UMLS (ICD9CM) C0202827) =Diagnostic Procedure
|
- 243. MAFG
- [Globin gene expression is regulated through NFE2 elements upstream of alpha- and beta-gene clusters. NFE2 DNA-binding involves a heterodimer containing a ubiquitous small MAF protein (MAFF, MAFG, or MAFK) and tissue-specific p45 NFE2. Both subunits are members of the AP-1-like superfamily of bZIP proteins. MAFG also forms heterodimers with NRF1 and NFE2-related factor 2, which stimulate transcription from NFE2 sites. (from OMIM 602020 and NCI) ( NCI )] (UMLS (NCI) C0534921) =Amino Acid, Peptide, or Protein; Biologically Active Substance
| - 293. Magnetic resonance imaging of musculoskeletal structures
- (UMLS (ICD9CM) C0202673) =Diagnostic Procedure
|
- 244. MAFG
- [This gene is involved in transcriptional regulation. ( NCI )] (UMLS (NCI) C0812300) MAFG Gene;
v-MAF Musculoaponeurotic Fibrosarcoma Oncogene Homolog G (Avian) Gene =Gene or Genome | - 294. Magnetic resonance imaging of pelvis, prostate, and bladder
- [ ] (UMLS (ICD9CM) C0203122) =Diagnostic Procedure
|
- 245. Mafoprazine
- (UMLS (NCI) C0065505) =Organic Chemical
| - 295. Magnetic resonance imaging of spinal canal
- [ ] (UMLS (ICD9CM) C0177803) =Diagnostic Procedure
|
- 246. MAFOSFAMIDE
- [A form of cyclophosphamide that can be administered as an intrathecal infusion. Mafosfamide is being studied as an anticancer drug. It belongs to the family of drugs called alkylating agents. ( NCI )] (UMLS (NCI) C0065506) =Organophosphorus Compound; Pharmacologic Substance ;
| - 296. Magnetic resonance spectroscopy
- [Magnetic resonance spectroscopic imaging. A noninvasive imaging method that provides information about cellular activity (metabolic information). It is used along with magnetic resonance imaging (MRI) which provides information about the shape and size of the tumor (spatial information). ( NCI )] (UMLS (HL7) C0024487) =Diagnostic Procedure ;
=Modality;
|
- 247. MAG (myelin associated glycoprotein)
- [family of heavily glycosylated, NCAM-like membrane proteins that serve to glue the extracellular faces of myelin lamellae in tight apposition; transient expression may control the spiral wrapping of the myelin sheath around an axon. ( CSP )] (UMLS (CSP) C0129439) =Amino Acid, Peptide, or Protein; Neuroreactive Substance or Biogenic Amine ;
=glycoprotein;
nerve/myelin protein | - 297. magnetic therapy
- [ ] (UMLS (CSP) C0872210) =Therapeutic or Preventive Procedure ;
|
- 248. magainin
- [A class of antimicrobial peptides discovered in the skin of XENOPUS LAEVIS. They kill bacteria by permeabilizing cell membranes without exhibiting significant toxicity against mammalian cells. ( MSH )] (UMLS (CSP) C0597875) =Amino Acid, Peptide, or Protein; Pharmacologic Substance
| - 298. magnetoencephalography
- [measurement of magnetic activity of the brain, usually conducted externally by sensitive devices such as SQUID's; electric currents generated in the brain by neural activity are accompanied by orthogonal magnetic fields and the measurement of these fields provide information about the localization of brain activity which is complementary to that provided by electroencephalography. ( CSP )] (UMLS (CSP) C0024489) =Diagnostic Procedure ;
=encephalography;
biomagnetism measurement |
- 249. MAGE-1 Antigen
- [A cancer specific antigen expressed by the melanoma antigen gene. ( NCI )] (UMLS (NCI) C0126758) =Amino Acid, Peptide, or Protein; Immunologic Factor
| - 299. magnetometry
- [ ] (UMLS (CSP) C0024490) =Occupational Activity ;
|
- 250. MAGE-10.A2
- [A synthetic nonapeptide derived from a melanoma-associated antigen. Vaccination with MAGE-10.A2 may stimulate a host cytotoxic T-cell response against tumor cells that express the melanoma-associated antigen, resulting in tumor cell lysis. (NCI04) ( NCI )] (UMLS (NCI) C1134715) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor
| - 300. Magnifier
- [An optical device that enlarges the apparent size of an image or object. ( NCI )] (UMLS (NCI) C0445078) =Medical Device ;
|
home
